Lao People's Democratic Republic vs United Arab Emirates: Share of E. coli infections resistant to cephalosporins
Lao People's Democratic Republic
52.6%
in 2022
United Arab Emirates
52.4%
in 2022
Lao People's Democratic Republic rank
16th
United Arab Emirates rank
17th
Share of E. coli infections resistant to cephalosporins over time
- Lao People's Democratic Republic
- United Arab Emirates
How they compare
Lao People's Democratic Republic currently reports 52.6% against 52.4% in United Arab Emirates, a difference of 0.2%.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was United Arab Emirates ahead.
Lao People's Democratic Republic ranks 16th and United Arab Emirates ranks 17th of 46 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.9% | 47.5% | 0.6% | United Arab Emirates |
| 2020s | 49.7% | 52.7% | 3.0% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Lao People's Democratic Republic or United Arab Emirates?
- Lao People's Democratic Republic, at 52.6% against 52.4% in United Arab Emirates as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Lao People's Democratic Republic and United Arab Emirates?
- 0.2%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and United Arab Emirates?
- 6 years are reported by both, from 2017 to 2022.
- How do Lao People's Democratic Republic and United Arab Emirates rank globally for share of e. coli infections resistant to cephalosporins?
- Lao People's Democratic Republic ranks 16th and United Arab Emirates ranks 17th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).